FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034808857> ?p ?o ?g. }

• W2034808857 endingPage "3143" @default.
• W2034808857 startingPage "3137" @default.
• W2034808857 abstract "The objective of the present study was to assess the safety and tolerability of cefazolin therapy among patients with methicillin-sensitive Gram-positive bacterial infections who develop non-IgE-mediated hypersensitivity reactions (HSRs) to nafcillin. In this retrospective cohort analysis of the Outpatient Parenteral Antimicrobial Therapy program at the Massachusetts General Hospital from 2007 through 2013, we identified patients switched from nafcillin to cefazolin after an immune-mediated HSR. We reviewed patient demographics, details about the original HSR, and outcomes after the switch to cefazolin therapy. HSRs were classified by reaction type and likely mechanism. There were 467 patients treated with nafcillin, of which 60 (12.8%) were switched to cefazolin during their prescribed course. Of the 60 patients who transitioned to cefazolin, 17 (28.3%) were switched because of non-IgE-mediated HSRs. HSRs included maculopapular rash (n = 10), immune-mediated nephritis (n = 3), isolated eosinophilia (n = 2), immune-mediated hepatitis (n = 1), and a serum sickness-like reaction (n = 1). All but one patient (94.1%) who switched to cefazolin tolerated the drug with resolution of the HSR and completed their therapy with cefazolin. No patient experienced worsening of their rash or progressive organ dysfunction. With appropriate monitoring, therapy with cefazolin after non-IgE-mediated HSRs to nafcillin appears to be safe." @default.
• W2034808857 created "2016-06-24" @default.
• W2034808857 creator A5006342786 @default.
• W2034808857 creator A5038528775 @default.
• W2034808857 creator A5039406963 @default.
• W2034808857 creator A5059386925 @default.
• W2034808857 creator A5087244157 @default.
• W2034808857 date "2014-06-01" @default.
• W2034808857 modified "2023-09-27" @default.
• W2034808857 title "Tolerability of Cefazolin after Immune-Mediated Hypersensitivity Reactions to Nafcillin in the Outpatient Setting" @default.
• W2034808857 cites W1441666804 @default.
• W2034808857 cites W1516573983 @default.
• W2034808857 cites W1572509795 @default.
• W2034808857 cites W1606035942 @default.
• W2034808857 cites W1854257504 @default.
• W2034808857 cites W190135249 @default.
• W2034808857 cites W1964956727 @default.
• W2034808857 cites W1973359676 @default.
• W2034808857 cites W1973473578 @default.
• W2034808857 cites W1975781941 @default.
• W2034808857 cites W1986316649 @default.
• W2034808857 cites W1995792510 @default.
• W2034808857 cites W2002282539 @default.
• W2034808857 cites W2007059813 @default.
• W2034808857 cites W2014810381 @default.
• W2034808857 cites W2015261002 @default.
• W2034808857 cites W2015812881 @default.
• W2034808857 cites W2020861464 @default.
• W2034808857 cites W2021830846 @default.
• W2034808857 cites W2022907333 @default.
• W2034808857 cites W2023456927 @default.
• W2034808857 cites W2023706681 @default.
• W2034808857 cites W2045190713 @default.
• W2034808857 cites W2046540943 @default.
• W2034808857 cites W2058135148 @default.
• W2034808857 cites W2067082896 @default.
• W2034808857 cites W2069414335 @default.
• W2034808857 cites W2072248123 @default.
• W2034808857 cites W2082441919 @default.
• W2034808857 cites W2091884920 @default.
• W2034808857 cites W2098036166 @default.
• W2034808857 cites W2106152381 @default.
• W2034808857 cites W2108072142 @default.
• W2034808857 cites W2110987545 @default.
• W2034808857 cites W2116754268 @default.
• W2034808857 cites W2116816874 @default.
• W2034808857 cites W2119591129 @default.
• W2034808857 cites W2125475413 @default.
• W2034808857 cites W2127412099 @default.
• W2034808857 cites W2127708887 @default.
• W2034808857 cites W2128682016 @default.
• W2034808857 cites W2130566249 @default.
• W2034808857 cites W2131190372 @default.
• W2034808857 cites W2133120422 @default.
• W2034808857 cites W2136352256 @default.
• W2034808857 cites W2141994303 @default.
• W2034808857 cites W2142165455 @default.
• W2034808857 cites W2143191716 @default.
• W2034808857 cites W2144551134 @default.
• W2034808857 cites W2145826475 @default.
• W2034808857 cites W2171665402 @default.
• W2034808857 cites W2339612342 @default.
• W2034808857 cites W4206515588 @default.
• W2034808857 cites W4214754383 @default.
• W2034808857 cites W4249148562 @default.
• W2034808857 doi "https://doi.org/10.1128/aac.02504-13" @default.
• W2034808857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4068447" @default.
• W2034808857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24637693" @default.
• W2034808857 hasPublicationYear "2014" @default.
• W2034808857 type Work @default.
• W2034808857 sameAs 2034808857 @default.
• W2034808857 citedByCount "19" @default.
• W2034808857 countsByYear W20348088572014 @default.
• W2034808857 countsByYear W20348088572015 @default.
• W2034808857 countsByYear W20348088572016 @default.
• W2034808857 countsByYear W20348088572017 @default.
• W2034808857 countsByYear W20348088572018 @default.
• W2034808857 countsByYear W20348088572019 @default.
• W2034808857 countsByYear W20348088572020 @default.
• W2034808857 countsByYear W20348088572021 @default.
• W2034808857 countsByYear W20348088572023 @default.
• W2034808857 crossrefType "journal-article" @default.
• W2034808857 hasAuthorship W2034808857A5006342786 @default.
• W2034808857 hasAuthorship W2034808857A5038528775 @default.
• W2034808857 hasAuthorship W2034808857A5039406963 @default.
• W2034808857 hasAuthorship W2034808857A5059386925 @default.
• W2034808857 hasAuthorship W2034808857A5087244157 @default.
• W2034808857 hasBestOaLocation W20348088571 @default.
• W2034808857 hasConcept C126322002 @default.
• W2034808857 hasConcept C174802600 @default.
• W2034808857 hasConcept C197934379 @default.
• W2034808857 hasConcept C203014093 @default.
• W2034808857 hasConcept C2778353156 @default.
• W2034808857 hasConcept C2778375690 @default.
• W2034808857 hasConcept C2778570526 @default.
• W2034808857 hasConcept C2780515650 @default.
• W2034808857 hasConcept C42219234 @default.
• W2034808857 hasConcept C501593827 @default.

• next